READD-ADSP: Building a diverse genetic resource for Alzheimer’s disease
Official title: Recruitment and Retention for Alzheimer's Disease Diversity Genetic Cohorts in the ADSP (READD-ADSP)
Funded at University of Miami School of Medicine · NIH-11563826 · Data updated 2026-11-12
A large, diverse group of people will give DNA and health information to help us understand how genetics influence Alzheimer’s across different populations.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Miami School of Medicine NIH-funded |
| Lab location | 1 site (Coral Gables, United States) |
| Project start | July 1, 2022 |
| Project end | June 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $51,865 |
| NIH project number | 3U19AG074865-05S5 |
| Project ID | NIH-11563826 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals of African, African American, or Hispanic/Latino ancestry who may be interested in contributing to a large genetic and clinical study of Alzheimer’s disease.
✕Less likely to help
If you do not have or are not at risk for Alzheimer’s, you may not directly benefit from this study.
What this research studies
This project will create a big genomics resource to study Alzheimer’s disease in people with African, African American, and Hispanic/Latino ancestry. Researchers will recruit about 13,000 individuals, collect clinical and genetic data, and harmonize these data with existing Alzheimer’s genomics projects. The work will include two hypothesis-driven projects to show how this resource can reveal genetic risk factors in diverse populations. The overall aim is to improve understanding of why Alzheimer’s risk differs by ancestry and to support future studies and therapies. Participation may involve blood samples, interviews, and health information sharing with consent.
Why it matters
Potential benefit: This resource could lead to better, more inclusive understanding of genetic risk for Alzheimer’s and inform personalized prevention and treatment strategies.
How similar studies have gone: Previous efforts show that diverse genetic data can uncover novel risk factors not seen in other populations, though this project expands and strengthens those efforts.
Where this research is happening
-
University of Miami School of Medicine
Coral Gables, United States Active
Researchers
- Principal investigator: Pericak-Vance, Margaret a. — University of Miami School of Medicine
- Study coordinator: Pericak-Vance, Margaret a.
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.